Spyre Therapeutics Stock Price on December 24, 2024

SYRE Stock   23.34  0.52  2.18%   
Below is the normalized historical share price chart for Spyre Therapeutics extending back to April 07, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Spyre Therapeutics stands at 23.34, as last reported on the 24th of December, with the highest price reaching 23.64 and the lowest price hitting 22.73 during the day.
IPO Date
7th of April 2016
200 Day MA
31.234
50 Day MA
30.2691
Beta
2.91
 
Covid
If you're considering investing in Spyre Stock, it is important to understand the factors that can impact its price. Spyre Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.048, which indicates the firm had a -0.048% return per unit of risk over the last 3 months. Spyre Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Spyre Therapeutics' Risk Adjusted Performance of (0.05), variance of 15.4, and Coefficient Of Variation of (1,358) to confirm the risk estimate we provide.
  
At present, Spyre Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 801.4 M, whereas Total Stockholder Equity is forecasted to decline to about 96.1 M. . At present, Spyre Therapeutics' Price Sales Ratio is projected to increase significantly based on the last few years of reporting. Spyre Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.048

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsSYRE

Estimated Market Risk

 3.93
  actual daily
34
66% of assets are more volatile

Expected Return

 -0.19
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Spyre Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spyre Therapeutics by adding Spyre Therapeutics to a well-diversified portfolio.
Price Book
8.1745
Enterprise Value Ebitda
(7.96)
Price Sales
2.2 K
Shares Float
32.8 M
Wall Street Target Price
58.625

Spyre Therapeutics Valuation on December 24, 2024

It is possible to determine the worth of Spyre Therapeutics on a given historical date. On December 24, 2024 Spyre was worth 23.86 at the beginning of the trading date compared to the closed value of 23.34. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Spyre Therapeutics stock. Still, in general, we apply an absolute valuation method to find Spyre Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Spyre Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Spyre Therapeutics' related companies.
 Open High Low Close Volume
  22.90    24.88    22.62    23.86    1,261,050  
12/24/2024
  23.86    23.64    22.73    23.34    231,281  
  23.86    23.64    22.73    23.34    231,281  
Backtest Spyre Therapeutics  |  Spyre Therapeutics History  |  Spyre Therapeutics Valuation   PreviousNext  
Open Value
23.86
23.34
Closing Value
35.64
Upside

Spyre Therapeutics Trading Date Momentum on December 24, 2024

On December 24 2024 Spyre Therapeutics was traded for  23.34  at the closing time. The top price for the day was 23.64  and the lowest listed price was  22.73 . The trading volume for the day was 231.3 K. The trading history from December 24, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 2.23% .

Spyre Therapeutics Fundamentals Correlations and Trends

By evaluating Spyre Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Spyre Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Spyre financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Spyre Therapeutics Stock history

Spyre Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Spyre is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Spyre Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Spyre Therapeutics stock prices may prove useful in developing a viable investing in Spyre Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding6.9 M7.2 M

Spyre Therapeutics Quarterly Net Working Capital

363.54 Million

Spyre Therapeutics Stock Technical Analysis

Spyre Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Spyre Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Spyre Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Spyre Therapeutics Period Price Range

Low
December 24, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Spyre Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Spyre Therapeutics December 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Spyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Spyre Therapeutics shares will generate the highest return on investment. By undertsting and applying Spyre Therapeutics stock market strength indicators, traders can identify Spyre Therapeutics entry and exit signals to maximize returns

Spyre Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Spyre Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Spyre Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Spyre to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Spyre Stock analysis

When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation